ALEMBIC DEFERASIROX deferasirox 180 mg film-coated tablet blister pack

Država: Australija

Jezik: engleski

Izvor: Department of Health (Therapeutic Goods Administration)

Aktivni sastojci:

deferasirox, Quantity: 180 mg

Dostupno od:

Alembic Pharmaceuticals Australia Pty Ltd

Farmaceutski oblik:

Tablet, film coated

Sastav:

Excipient Ingredients: crospovidone; poloxamer; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose; povidone; sodium starch glycollate type A; titanium dioxide; hypromellose; purified talc; macrogol 4000; indigo carmine aluminium lake

Administracija rute:

Oral

Jedinice u paketu:

30

Tip recepta:

(S4) Prescription Only Medicine

Terapijske indikacije:

The treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adults and paediatric patients 6 years and older. ALEMBIC DEFERASIROX is also indicated for the treatment of chronic iron overload in paediatric patients aged 2 to 5 years who are unable to take desferrioxamine therapy or in whom desferrioxamine has proven ineffective. ,ALEMBIC DEFERASIROX is also indicated for the treatment of chronic iron overload in patients with non-transfusion- dependent thalassemia syndromes aged 10 years and older.

Proizvod sažetak:

Visual Identification: Medium blue, oval, biconvex, film-coated tablet with beveled edges, debossed with "L" on one side and "664" on the other side. Approximately 13 mm in length and approximately 5 mm in width.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Status autorizacije:

Registered

Datum autorizacije:

2020-11-16